We first determined which tumor was responsive and unresponsive using an anti-PD-L1 monoclonal antibody (mAb) to block PD-1 signal (PD-1 blockade) or the Pdcd1-/- mouse model (Figure 1—figure supplement 1). The gene discussed is PDCD1; the disease is neoplasm.